Meeting Archive:
An ASBMR Webinar on Talking with Your Patients About Bisphosphonate Risks vs. Benefits: Perception vs. Reality

 
Sponsored by the ASBMR Professional Practice Committee
 
To listen to the recording and view the slides that were presented, click on the recording link on the right side of this screen. 
 

Meeting Description:

Randomized placebo-controlled trials in women with postmenopausal osteoporosis have shown that bisphosphonates (alendronate, risedronate, ibandronate, zoledronate) reduce fracture risk with a favorable balance of benefit and risk. With the use of these agents in millions of clinical practice patients, safety concerns, particularly osteonecrosis of the jaw and atypical femur fractures, have emerged.  This webinar focuses on strategies for communicating the balance of benefit and risk to patients in order to optimize clinical outcomes.

As a result of this webinar participants will be able to:
 
  • Identify patients most likely to benefit from bisphosphonate therapy to reduce fracture risk
  • Understand the evidence for risks of bisphosphonate therapy
  • Communicate the balance of benefit and risk to patients
  • Use FRAX and other fracture risk calculators as risk communication tools
  • Describe decision aids for risk communication
  • Engage patients in the process of shared decision making
 
Details
Date: Tue, Nov 13, 2012
Time: 11:00 AM EST
Duration: 1 hour
Host(s): American Society for Bone and Mineral Research
 Presenter Information
E. Michael Lewiecki, MD, FACP, FACE
Speaker Photo

E. Michael Lewiecki, MD, FACP, FACE, is Clinical Assistant Professor of Medicine at University of New Mexico School of Medicine and Director of New Mexico Clinical Research & Osteoporosis Center. He has been principal investigator for many osteoporosis clinical trials and author of numerous scientific publications on osteoporosis and bone densitometry. Dr. Lewiecki is past-president of the International Society for Clinical Densitometry and serves in editorial positions for several journals devoted to clinical investigation, osteoporosis, and assessment of skeletal health.


Neil C. Binkley, MD
Speaker Photo

Dr. Neil C. Binkley earned his degree from the University of Wisconsin Medical School and subsequently received his training in Internal Medicine at the Marshfield Clinic. After several years in private practice, he returned to the University of Wisconsin in 1990 and completed a geriatric fellowship. He is board certified in Internal Medicine and Geriatrics. In 1994 he was instrumental in establishing the UW Osteoporosis Clinical Center and the Osteoporosis Clinical Research Program, offering treatment options unavailable in standard clinical practice.